Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with chronic plaque-type psoriasis, either based on a doctor's clinical assessment or confirmed through a tissue sample (biopsy)
- People who are willing to sign a consent form showing they understand what the study involves and agree to take part
Who may not be able to join:
- People whose psoriasis is mainly a non-plaque type (for example, guttate or pustular psoriasis) at the time of the study
- People who are currently pregnant, breastfeeding, or planning to become pregnant
- People who are unable or unwilling to have multiple blood draws during the study
- People who are taking brodalumab on a dosing schedule that differs from the standard recommended dosing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jo Lambert, Prof., University Ghent
Phone: 09 332 22 87
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of early serum trough concentrations of brodalumab; Predictive value of early anti-drug antibodies of brodalumab; The development of a therapeutic window of brodalumab in psoriasis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.